Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Depreciation & Amortization (IS)EBIATLeasesLong-Term Debt IssuancesOther Gross PP&E AdjustmentsShares Issued
Ratios

Amylyx Pharmaceuticals (AMLX) Depreciation & Amortization (IS) (2024 - 2025)

Historic Depreciation & Amortization (IS) for Amylyx Pharmaceuticals (AMLX) over the last 2 years, with Q3 2025 value amounting to $100000.0.

  • Amylyx Pharmaceuticals' Depreciation & Amortization (IS) fell 5000.0% to $100000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $600000.0, marking a year-over-year change of. This contributed to the annual value of $900000.0 for FY2024, which is 1818.18% down from last year.
  • Latest data reveals that Amylyx Pharmaceuticals reported Depreciation & Amortization (IS) of $100000.0 as of Q3 2025, which was down 5000.0% from $100000.0 recorded in Q2 2025.
  • Over the past 5 years, Amylyx Pharmaceuticals' Depreciation & Amortization (IS) peaked at $300000.0 during Q1 2024, and registered a low of $100000.0 during Q2 2025.